512 related articles for article (PubMed ID: 22385240)
1. Excessive CD4+ T cells co-expressing interleukin-17 and interferon-γ in patients with Behçet's disease.
Shimizu J; Takai K; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Suzuki N
Clin Exp Immunol; 2012 Apr; 168(1):68-74. PubMed ID: 22385240
[TBL] [Abstract][Full Text] [Related]
2. Th17-Inducing Conditions Lead to in vitro Activation of Both Th17 and Th1 Responses in Behcet's Disease.
Deniz R; Tulunay-Virlan A; Ture Ozdemir F; Unal AU; Ozen G; Alibaz-Oner F; Aydin-Tatli I; Mumcu G; Ergun T; Direskeneli H
Immunol Invest; 2017 Jul; 46(5):518-525. PubMed ID: 28414558
[TBL] [Abstract][Full Text] [Related]
3. Effect of 1,25-dihydroxyvitamin D3 on Th17 and Th1 response in patients with Behçet's disease.
Tian Y; Wang C; Ye Z; Xiao X; Kijlstra A; Yang P
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6434-41. PubMed ID: 22918640
[TBL] [Abstract][Full Text] [Related]
4. Imbalance of Th17 to Th1 cells in Behçet's disease.
Kim J; Park JA; Lee EY; Lee YJ; Song YW; Lee EB
Clin Exp Rheumatol; 2010; 28(4 Suppl 60):S16-9. PubMed ID: 20868565
[TBL] [Abstract][Full Text] [Related]
5. Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease.
Lucherini OM; Lopalco G; Cantarini L; Emmi G; Lopalco A; Venerito V; Vitale A; Iannone F
Immunol Lett; 2018 Sep; 201():38-44. PubMed ID: 30385329
[TBL] [Abstract][Full Text] [Related]
6. IFN-α induces IL-10 production and tilt the balance between Th1 and Th17 in Behçet disease.
Touzot M; Cacoub P; Bodaghi B; Soumelis V; Saadoun D
Autoimmun Rev; 2015 May; 14(5):370-5. PubMed ID: 25541082
[TBL] [Abstract][Full Text] [Related]
7. Skewed TGFβ/Smad signalling pathway in T cells in patients with Behçet's disease.
Shimizu J; Izumi T; Arimitsu N; Fujiwara N; Ueda Y; Wakisaka S; Yoshikawa H; Kaneko F; Suzuki T; Takai K; Suzuki N
Clin Exp Rheumatol; 2012; 30(3 Suppl 72):S35-9. PubMed ID: 22935165
[TBL] [Abstract][Full Text] [Related]
8. Increased entry of CD4+ T cells into the Th1 cytokine effector pathway during T-cell division following stimulation in Behcet's disease.
Koarada S; Haruta Y; Tada Y; Ushiyama O; Morito F; Ohta A; Nagasawa K
Rheumatology (Oxford); 2004 Jul; 43(7):843-51. PubMed ID: 15150429
[TBL] [Abstract][Full Text] [Related]
9. Activation of the liver X receptor inhibits Th17 and Th1 responses in Behcet's disease and Vogt-Koyanagi-Harada disease.
Wu L; Wen H; Zhou Y; Yu H; Liu Y; Bai L; Kijlstra A; Yang P
Curr Mol Med; 2014; 14(6):712-22. PubMed ID: 25056541
[TBL] [Abstract][Full Text] [Related]
10. Skewed Th1 responses caused by excessive expression of Txk, a member of the Tec family of tyrosine kinases, in patients with Behcet's disease.
Suzuki N; Nara K; Suzuki T
Clin Med Res; 2006 Jun; 4(2):147-51. PubMed ID: 16809408
[TBL] [Abstract][Full Text] [Related]
11. TGF-β converts Th1 cells into Th17 cells through stimulation of Runx1 expression.
Liu HP; Cao AT; Feng T; Li Q; Zhang W; Yao S; Dann SM; Elson CO; Cong Y
Eur J Immunol; 2015 Apr; 45(4):1010-8. PubMed ID: 25605286
[TBL] [Abstract][Full Text] [Related]
12. Excessive expression of Txk, a member of the Tec family of tyrosine kinases, contributes to excessive Th1 cytokine production by T lymphocytes in patients with Behcet's disease.
Nagafuchi H; Takeno M; Yoshikawa H; Kurokawa MS; Nara K; Takada E; Masuda C; Mizoguchi M; Suzuki N
Clin Exp Immunol; 2005 Feb; 139(2):363-70. PubMed ID: 15654836
[TBL] [Abstract][Full Text] [Related]
13. Increased frequencies of interleukin-2- and interferon-gamma-producing T cells in patients with active Behçet's disease.
Sugi-Ikai N; Nakazawa M; Nakamura S; Ohno S; Minami M
Invest Ophthalmol Vis Sci; 1998 May; 39(6):996-1004. PubMed ID: 9579479
[TBL] [Abstract][Full Text] [Related]
14. IL-7/IL-7 Receptor Signaling Differentially Affects Effector CD4+ T Cell Subsets Involved in Experimental Autoimmune Encephalomyelitis.
Arbelaez CA; Glatigny S; Duhen R; Eberl G; Oukka M; Bettelli E
J Immunol; 2015 Sep; 195(5):1974-83. PubMed ID: 26223651
[TBL] [Abstract][Full Text] [Related]
15. Effect of Interferon alfa-2a Treatment on Adaptive and Innate Immune Systems in Patients With Behçet Disease Uveitis.
Albayrak O; Oray M; Can F; Uludag Kirimli G; Gul A; Tugal-Tutkun I; Onal S
Invest Ophthalmol Vis Sci; 2019 Jan; 60(1):52-63. PubMed ID: 30601931
[TBL] [Abstract][Full Text] [Related]
16. Possible association of proinflammatory cytokines including IL1β and TNFα with enhanced Th17 cell differentiation in patients with Behcet's disease.
Shimizu J; Takai K; Takada E; Fujiwara N; Arimitsu N; Ueda Y; Wakisaka S; Suzuki T; Suzuki N
Clin Rheumatol; 2016 Jul; 35(7):1857-63. PubMed ID: 25972082
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of Th17 and related cytokines in Behçet's disease corresponding to disease activity.
Na SY; Park MJ; Park S; Lee ES
Clin Exp Rheumatol; 2013; 31(3 Suppl 77):32-40. PubMed ID: 24064012
[TBL] [Abstract][Full Text] [Related]
18. IL-22-secreting Th22 and IFN-γ-secreting Th17 cells in Behçet's disease.
Aktas Cetin E; Cosan F; Cefle A; Deniz G
Mod Rheumatol; 2014 Sep; 24(5):802-7. PubMed ID: 24498963
[TBL] [Abstract][Full Text] [Related]
19. Th1 and Th17 cytokines drive inflammation in Takayasu arteritis.
Saadoun D; Garrido M; Comarmond C; Desbois AC; Domont F; Savey L; Terrier B; Geri G; Rosenzwajg M; Klatzmann D; Fourret P; Cluzel P; Chiche L; Gaudric J; Koskas F; Cacoub P
Arthritis Rheumatol; 2015 May; 67(5):1353-60. PubMed ID: 25604824
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Th17 differentiation by anti-TNF-alpha therapy in uveitis patients with Behçet's disease.
Sugita S; Kawazoe Y; Imai A; Yamada Y; Horie S; Mochizuki M
Arthritis Res Ther; 2012 May; 14(3):R99. PubMed ID: 22546542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
